Aspire Biopharma (ASBP) Financials: Revenue & Earnings
ASBP$8.88+0.44 +5.21%
$1.02M
Market Cap
—
P/E
—
Forward P/E
—
Score
Aspire Biopharma (ASBP) Financials: Revenue & Earnings
ASBP price $8.88 +0.44 +5.21%
- Ticker
- ASBP
- Price
- $8.88
- Change
- +0.44 +5.21%
- Market cap ?
- $1.02M
- Beta ?
- 0.15
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
Fair value
ASBP fair value $360.32. Price $8.88. Price is 98% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-08-13 | -1.00 | — | 63.10K | — |
| 2026-05-15 | -20.57 | — | 28.35K | — |
| 2026-03-30 | -3.15 | — | 4.26K | — |
| 2025-11-14 | -0.04 | — | 1.94K | — |
| 2025-08-13 | -0.04 | — | — | — |
| 2025-05-14 | -16.80 | — | — | — |
| 2025-04-07 | -0.28 | — | — | — |
| 2024-11-14 | -0.02 | — | — | — |
| 2024-08-16 | -0.02 | — | — | — |
| 2024-06-05 | -0.07 | — | — | — |
| 2024-03-11 | -0.00 | — | — | — |
| 2023-11-07 | -0.00 | — | — | — |
| 2023-08-08 | 0.01 | — | — | — |
| 2023-05-11 | 0.02 | — | — | — |
| 2023-03-21 | 0.02 | — | — | — |
| 2022-11-10 | 0.01 | — | — | — |
| 2022-08-11 | 0.00 | — | — | — |
| 2022-05-16 | -0.00 | — | — | — |
| 2021-12-31 | -0.00 | — | — | — |
| 2021-09-30 | -0.00 | — | — | — |
| 2021-06-30 | -0.00 | — | — | — |
| 2021-03-31 | -0.00 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2025-06-05 | Fell Donald G. | Buy | 10.50K | $0.39 | 4.09K |
| 2025-06-05 | Fell Donald G. | Sell | 10.50K | $0.39 | 4.09K |
| 2025-06-04 | Fell Donald G. | Buy | 9.50K | $0.39 | 3.71K |
| 2025-06-04 | Fell Donald G. | Sell | 9.50K | $0.39 | 3.71K |
| 2023-08-18 | AJJARAPU SURENDRA K | Other | 0 | — | — |
| 2023-08-18 | AJJARAPU SURENDRA K | Other | 6.83M | $11.50 | 78.59M |
| 2023-08-18 | Doshi Mayur Mansukhlal | Other | 0 | — | — |
| 2023-08-18 | Wadhwani Avinash R | Other | 0 | — | — |
| 2023-08-18 | PETERSON MICHAEL L | Other | 0 | — | — |
| 2023-08-18 | Fell Donald G. | Other | 0 | — | — |
| 2023-08-18 | Doss Howard A. | Other | 0 | — | — |
| 2023-08-18 | PowerUp Sponsor LLC | Sell | 4.32M | $0.00 | 432 |
| 2023-05-18 | PowerUp Sponsor LLC | Buy | 7.19M | — | — |
| 2023-05-18 | PowerUp Sponsor LLC | Sell | 7.19M | — | — |
| 2022-02-17 | Hack Bruce L. | Other | 7.19M | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CROSSINGBRIDGE ADVISORS, LLC | 0 | -24.35K | -100.00% | 0 |
Earnings and financials
Aspire Biopharma Holdings, Inc. (ASBP) trades at $8.88, with a market cap of $1.02M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn